Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China flag China · Delayed Price · Currency is CNY
29.61
-0.73 (-2.41%)
Oct 29, 2026, 3:00 PM CST

SHE:300957 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,6072,4581,8102,0912,5142,035
Short-Term Investments
---310480.121,530
Trading Asset Securities
2,2901,8502,4281,2381,434781.15
Cash & Short-Term Investments
3,8974,3084,2393,6404,4284,346
Cash Growth
-1.10%1.64%16.45%-17.80%1.89%477.93%
Accounts Receivable
472.47740.041,047742.92508.76328.3
Other Receivables
42.65198.92173.14157.8720.4737.81
Receivables
515.11938.961,220900.79529.23366.11
Inventory
757.93528.46611.89904.41670.75463.27
Prepaid Expenses
-0.966.956.98-2.92
Other Current Assets
284.9491.5955.3170.5787.0146.95
Total Current Assets
5,4555,8686,1335,5235,7155,225
Property, Plant & Equipment
774.43854.91936.82808.14665.36431.96
Long-Term Investments
645.66495.26375.95298.4682.78-
Goodwill
292.5292.5323.05413.74--
Other Intangible Assets
553.43551.79258.52193.1177.9464.59
Long-Term Deferred Tax Assets
157.6148.86129.3493.1352.1215.58
Long-Term Deferred Charges
70.42106.89113.5993.3266.7341.02
Other Long-Term Assets
23.7523.0833.3884.4559.6334.31
Total Assets
7,9738,3418,3047,5076,7205,812

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
443.29446.91447.18401.93372.37361.61
Accrued Expenses
90.02356.03457.76469.93312.06285.73
Short-Term Debt
348.5480.64314.56103.82--
Current Portion of Leases
56.3271.0763.3342.162.4248.91
Current Income Taxes Payable
76.7147.9970105.22109.6997.54
Current Unearned Revenue
94.2280.4698.9750.0558.1271.19
Other Current Liabilities
215.6972.466.13118.1677.2134.78
Total Current Liabilities
1,3251,5561,5181,291991.87899.75
Long-Term Debt
277.78207.03321.664.7--
Long-Term Leases
54.3175.76118.2363.2850.9576.29
Long-Term Unearned Revenue
115.15161.56112.3782.8655.576.3
Long-Term Deferred Tax Liabilities
45.7335.0133.340.458.361.69
Other Long-Term Liabilities
25.031.9512.258.610.550
Total Liabilities
1,8432,0372,1161,4911,1171,034

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
423.6423.6423.6423.6423.6423.6
Additional Paid-In Capital
2,7232,8342,8172,8462,8462,846
Retained Earnings
3,1783,2052,9522,7012,2831,486
Treasury Stock
-278.85-144.96-144.96-109.84--
Comprehensive Income & Other
-0.41-159.992.050.05-00
Total Common Equity
6,0466,1576,0505,8615,5534,755
Minority Interest
84.22147.28137.92154.8249.4823.26
Shareholders' Equity
6,1306,3056,1886,0165,6024,778
Total Liabilities & Equity
7,9738,3418,3047,5076,7205,812

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
736.91834.5817.77213.9113.36125.2
Net Cash (Debt)
3,1603,4743,4213,4264,3154,221
Net Cash Growth
1.11%1.54%-0.14%-20.60%2.23%461.28%
Net Cash Per Share
7.508.248.168.1010.1810.37
Filing Date Shares Outstanding
417.17421.29421.29420.61423.6423.6
Total Common Shares Outstanding
417.17421.29421.29420.61423.6423.6
Working Capital
4,1304,3134,6154,2314,7234,325
Book Value Per Share
14.4914.6214.3613.9313.1111.23
Tangible Book Value
5,2005,3135,4685,2545,4754,691
Tangible Book Value Per Share
12.4712.6112.9812.4912.9211.07
Buildings
-265.79251.48261.250.3533.8
Machinery
-721.68649.81527.8228.01124.7
Construction In Progress
-12.5950.7640.22349.47197.29